Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A multicentre, retrospective study was performed, involving psoriatic patien...

Full description

Bibliographic Details
Main Authors: Céline Phan, Nathalie Beneton, Juliette Delaunay, Ziad Reguiai, Claire Boulard, Anne-Claire Fougerousse, Elisa Cinotti, Marco Romanelli, Laure Mery-Bossard, Domitille Thomas-Beaulieu, Josiane Parier, François Maccari, Jean-Luc Perrot, Mireille Ruer-Mulard, Marie Bastien, Edouard Begon, Mahtab Samimi, Caroline Jacobzone, Nathalie Quiles-Tsimaratos, Vincent Descamps, Maud Steff, Paul Bilan, Annie Vermersch-Langlin, Mathilde Kemula, Emmanuelle Amazan, Ingrid Kupfer-Bessaguet, Anne-Caroline Cottencin, Francesca Prignano, Bulai Livideanu, Jeremy Gottlieb, Alain Beauchet, Emmanuel Mahé
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2020-11-01
Series:Acta Dermato-Venereologica
Subjects:
psoriasis
anti-interleukin 17
elderly
safety
drug survival
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3678

Internet

https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3678

Similar Items